Novartis prioritizing animal-health sale over vaccine divestiture; Iran expands vaccine ambitions;

> Novartis ($NVS) is reportedly prioritizing the sale of its animal-health unit over the vaccine business. News

> Iran is planning to start manufacturing 7 vaccines to overcome supply shortages. Article

> Soligenix ($SNGX) has sent a contract proposal for development of a thermostable ricin vaccine to NIH. Release

> A computer algorithm could help researchers select the most promising vaccine candidates. Abstract

> Sanofi ($SNY) and the Thai government plan to upgrade the vaccine plant run by their joint venture. Piece

> Researchers have used AIMM Therapeutics' antibodies to develop a respiratory syncytial virus (RSV) vaccine candidate. Item

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.